X4 Pharmaceuticals (XFOR) Market Capitalization (2019 - 2026)

X4 Pharmaceuticals (XFOR) has reported Market Capitalization for 8 consecutive years, with $590.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization rose 3801.29% year-over-year to $590.0 million; the trailing twelve-month figure through Jun 2026 stood at $590.0 million (up 3801.29% YoY), and the FY2025 full-year result was $169.2 million, up 34.9% from the prior year.
• Market Capitalization grew to $590.0 million in Q2 2026 per XFOR's latest filing, from $521.6 million in the prior quarter.
• Across five years, Market Capitalization topped out at $9.6 billion in Q2 2023 and bottomed at $15.1 million in Q2 2025.
• Historically, Market Capitalization has averaged $2.5 billion across 5 years, with a median of $1.3 billion in 2022.
• The sharpest annual moves came in 2025 and 2026: Market Capitalization sank 99.57% in 2025, then jumped 3801.29% in 2026.
• Over 5 years, Market Capitalization stood at $1.9 billion in 2022, then jumped by 136.35% to $4.5 billion in 2023, then slumped by 97.2% to $125.4 million in 2024, then surged by 34.9% to $169.2 million in 2025, then jumped by 248.77% to $590.0 million in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $590.0 million, $521.6 million, and $169.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.